Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
18.05
+0.47 (2.67%)
At close: Jan 17, 2025, 4:00 PM
18.44
+0.39 (2.16%)
After-hours: Jan 17, 2025, 4:26 PM EST
Arvinas Employees
Arvinas had 445 employees as of December 31, 2023. The number of employees increased by 30 or 7.23% compared to the previous year.
Employees
445
Change (1Y)
30
Growth (1Y)
7.23%
Revenue / Employee
$362,022
Profits / Employee
-$693,483
Market Cap
1.24B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ARVN News
- 10 days ago - Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 6 weeks ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Shareholders to Inquire about Securities Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Shareholders to Connect - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Investors to Connect - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Stockholders to Inquire about Securities Investigation - Accesswire